Beginning in the early 1990s, a new era dawned in studies of neurotransmitter transporter structure, function, and regulation, illuminated by the cloning of transporter cDNAs and genes, the development of transporter-specific gene and protein probes, and the characterization of heterologous expression systems suitable for advanced biophysical analyses. Among the advances in this field over the next decade were the elucidation of critical domains and residues supporting substrate and antagonist recognition, the discovery that transporters exist as multimeric protein complexes, the definition of N-glycosylation and phosphorylation as important posttranslational modifications, the recognition that transporters exhibited ion-channel states, and the elucidation of the first human disorders associated with transporter mutations. Many reviews are available that highlight these and other areas (4-6, 8, 15, 20, 31, 51). Together, they illustrate a field reaching maturity, yet poised for renaissance, in which long-held ideas are challenged by new techniques and data. In this short review, we describe several new approaches and findings from our labs and from colleagues in the field that have challenged us to reconsider aspects of biogenic amine transporter structure, function, and regulation.
Substrate Binding and Transport: Watching Transporters at WorkThe measurements of substrate flux through neurotransmitter transporters has relied extensively on radiolabeled substrates. Although such molecules are sensitive probes for transporter activity from populations of transporter proteins, radiolabeled substrates have limited utility for the real-time monitoring of either binding or transport; they cannot illuminate a substrate's local environment or how it changes during substrate flux, and they cannot be used to identify cellular subdomains or relate population properties to individual molecules. Amperometric approaches offer some solutions to these limitations, as we will note below, but they are limited to paradigms such as in vitro (26, 45) or in vivo clearance measurements (10,14), in which the presence or absence of oxidizeable amine changes significantly as a function of time. Binding and transfer events that occur before changes in extracellular levels of diffusible neurotransmitter are achieved cannot be resolved. To move beyond these approaches, Schwartz et al. 1548-9213/05 8.00